 Connection
Michael Wachs to Treatment Outcome
This is a "connection" page, showing publications Michael Wachs has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.268 |
|
|
|
-
Chirichella TJ, Dunham CM, Zimmerman MA, Phelan EM, Mandell MS, Conzen KD, Kelley SE, Nydam TL, Bak TE, Kam I, Wachs ME. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol. 2016 Mar 28; 22(12):3392-403.
Score: 0.051
-
Bauer J, Johnson S, Durham J, Ludkowski M, Trotter J, Bak T, Wachs M. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl. 2006 Oct; 12(10):1544-51.
Score: 0.026
-
Slater K, Bak TE, Kam I, Wachs ME. Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava. Liver Transpl. 2004 Apr; 10(4):555-6.
Score: 0.022
-
Rolfes PS, Yoeli D, Feldman AG, Adams MA, Wachs ME, Boster JM. Modern-era successful liver transplantation outcomes in children with hepatic undifferentiated embryonal sarcoma. Pediatr Transplant. 2024 Feb; 28(1):e14645.
Score: 0.022
-
Ziogas IA, Schmoke N, Yoeli D, Cullen JM, Boster JM, Wachs ME, Adams MA. The effect of donor graft type on survival after liver transplantation for hepatoblastoma in children. Pediatr Transplant. 2024 Feb; 28(1):e14641.
Score: 0.022
-
Yoeli D, Feldman AG, Choudhury RA, Moore HB, Sundaram SS, Nydam TL, Wachs ME, Pomfret EA, Adams MA, Jackson WE. Can non-directed living liver donation help improve access to grafts and correct socioeconomic disparities in pediatric liver transplantation? Pediatr Transplant. 2023 03; 27(2):e14428.
Score: 0.020
-
Yoeli D, Choudhury RA, Nydam TL, Pomposelli JJ, Goss JA, Pomfret EA, Wachs ME, Adams MA. The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is It Time to Split the Difference? Transplantation. 2021 10 01; 105(10):2239-2244.
Score: 0.019
-
Feldman AG, Adams MA, Wachs ME, Abzug MJ, Pratscher L, Jackson WE, Pomfret EA, Sundaram SS. Successful non-directed living liver donor transplant for an infant with biliary atresia during the COVID-19 pandemic. Pediatr Transplant. 2020 12; 24(8):e13816.
Score: 0.017
-
Zimmerman MA, Kelly MA, Campsen J, Mandell MS, Wachs M, Bak T, Skibba A, Lancaster B, Kam I. The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation. Clin Transplant. 2010 Jul-Aug; 24(4):E103-8.
Score: 0.009
-
Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Wright F, Kam I. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl. 2008 Sep; 14(9):1281-6.
Score: 0.008
-
Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Skibba A, Kam I. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl. 2008 May; 14(5):633-8.
Score: 0.007
-
Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam I. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl. 2008 Feb; 14(2):181-5.
Score: 0.007
-
Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Wright F, Steinberg T, Bennett W, Kam I. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transpl Int. 2007 Sep; 20(9):747-53.
Score: 0.007
-
Trotter JF, Campsen J, Bak T, Wachs M, Forman L, Everson G, Kam I. Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant. 2006 Aug; 6(8):1882-9.
Score: 0.007
-
Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 2003 Jul; 9(7):737-40.
Score: 0.005
-
Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med. 2002 Apr 04; 346(14):1074-82.
Score: 0.005
-
Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, Everson G. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. Liver Transpl. 2001 May; 7(5):401-8.
Score: 0.005
-
Trouillot TE, Shrestha R, Kam I, Wachs M, Everson GT. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg. 1999 Sep; 5(5):375-80.
Score: 0.004
-
Shrestha R, Durham JD, Wachs M, Bilir BM, Kam I, Trouillot T, Everson GT. Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome. Am J Gastroenterol. 1997 Dec; 92(12):2304-6.
Score: 0.004
-
Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC. Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg. 1995 Aug; 130(8):824-30; discussion 830-1.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|